Cimerli 70114-0441-01
Generic: Ranibizumab-Eqrn
- Manufacturer
- Coherus Biosciences Inc
- Dosage Form
- Injection, Solution
- Route
- Intravitreal
- Product Type
- Human Prescription Drug
- Marketing Start
- October 3, 2022
- Application
- BLA761165
Need to source Cimerli? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ranibizumab | .5 mg/.05mL |
Drug Class
Vascular Endothelial Growth Factor Inhibitor [EPC]Vascular Endothelial Growth Factor Inhibitor [EPC]Vascular Endothelial Growth Factor Inhibitors [MoA]
Selected Package
70114-0441-01Selected1 VIAL, SINGLE-DOSE in 1 CARTON (70114-441-01) / .05 mL in 1 VIAL, SINGLE-DOSE